178 related articles for article (PubMed ID: 26205261)
1. Posttranscriptional regulation of T-type Ca(2+) channel expression by interleukin-6 in prostate cancer cells.
Weaver EM; Zamora FJ; Hearne JL; Martin-Caraballo M
Cytokine; 2015 Dec; 76(2):309-320. PubMed ID: 26205261
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor signaling regulates T-type Ca
Hall M; Todd B; Allen ED; Nguyen N; Kwon YJ; Nguyen V; Hearne JL; Martin-Caraballo M
Am J Cancer Res; 2018; 8(4):732-747. PubMed ID: 29736318
[TBL] [Abstract][Full Text] [Related]
3. Functional upregulation of the H2S/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells.
Fukami K; Sekiguchi F; Yasukawa M; Asano E; Kasamatsu R; Ueda M; Yoshida S; Kawabata A
Biochem Pharmacol; 2015 Oct; 97(3):300-9. PubMed ID: 26256074
[TBL] [Abstract][Full Text] [Related]
4. Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells.
Weaver EM; Zamora FJ; Puplampu-Dove YA; Kiessu E; Hearne JL; Martin-Caraballo M
Eur J Pharmacol; 2015 Feb; 749():20-31. PubMed ID: 25557765
[TBL] [Abstract][Full Text] [Related]
5. [Role of Ca
Sekiguchi F; Kawabata A
Nihon Yakurigaku Zasshi; 2019; 154(3):97-102. PubMed ID: 31527367
[TBL] [Abstract][Full Text] [Related]
6. IL-6 evoked biochemical changes in prostate cancer cells.
Bennett JL; Jackson BN; Miller RJ; Tsui H; Martin-Caraballo M
Cytokine; 2023 Jan; 161():156079. PubMed ID: 36372008
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
[TBL] [Abstract][Full Text] [Related]
8. CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells.
Gackière F; Bidaux G; Delcourt P; Van Coppenolle F; Katsogiannou M; Dewailly E; Bavencoffe A; Van Chuoï-Mariot MT; Mauroy B; Prevarskaya N; Mariot P
J Biol Chem; 2008 Apr; 283(15):10162-73. PubMed ID: 18230611
[TBL] [Abstract][Full Text] [Related]
9. High glucose induces N-linked glycosylation-mediated functional upregulation and overexpression of Ca
Fukami K; Asano E; Ueda M; Sekiguchi F; Yoshida S; Kawabata A
J Pharmacol Sci; 2017 Jan; 133(1):57-60. PubMed ID: 28081948
[TBL] [Abstract][Full Text] [Related]
10. AMPK/SIRT1 signaling through p38MAPK mediates Interleukin-6 induced neuroendocrine differentiation of LNCaP prostate cancer cells.
Natani S; Dhople VM; Parveen A; Sruthi KK; Khilar P; Bhukya S; Ummanni R
Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119085. PubMed ID: 34171447
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 induces neuroendocrine differentiation (NED) through suppression of RE-1 silencing transcription factor (REST).
Zhu Y; Liu C; Cui Y; Nadiminty N; Lou W; Gao AC
Prostate; 2014 Aug; 74(11):1086-94. PubMed ID: 24819501
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells.
Mariot P; Vanoverberghe K; Lalevee N; Rossier MF; Prevarskaya N
J Biol Chem; 2002 Mar; 277(13):10824-33. PubMed ID: 11799114
[TBL] [Abstract][Full Text] [Related]
13. Subtype switching of T-type Ca 2+ channels from Cav3.2 to Cav3.1 during differentiation of embryonic stem cells to cardiac cell lineage.
Mizuta E; Miake J; Yano S; Furuichi H; Manabe K; Sasaki N; Igawa O; Hoshikawa Y; Shigemasa C; Nanba E; Ninomiya H; Hidaka K; Morisaki T; Tajima F; Hisatome I
Circ J; 2005 Oct; 69(10):1284-9. PubMed ID: 16195632
[TBL] [Abstract][Full Text] [Related]
14. Wnt-11 promotes neuroendocrine-like differentiation, survival and migration of prostate cancer cells.
Uysal-Onganer P; Kawano Y; Caro M; Walker MM; Diez S; Darrington RS; Waxman J; Kypta RM
Mol Cancer; 2010 Mar; 9():55. PubMed ID: 20219091
[TBL] [Abstract][Full Text] [Related]
15. Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP-1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer.
Gong Y; Chippada-Venkata UD; Galsky MD; Huang J; Oh WK
Prostate; 2015 May; 75(6):616-27. PubMed ID: 25560638
[TBL] [Abstract][Full Text] [Related]
16. Autophagy pathway is required for IL-6 induced neuroendocrine differentiation and chemoresistance of prostate cancer LNCaP cells.
Chang PC; Wang TY; Chang YT; Chu CY; Lee CL; Hsu HW; Zhou TA; Wu Z; Kim RH; Desai SJ; Liu S; Kung HJ
PLoS One; 2014; 9(2):e88556. PubMed ID: 24551118
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
Hobisch A; Ramoner R; Fuchs D; Godoy-Tundidor S; Bartsch G; Klocker H; Culig Z
Clin Cancer Res; 2001 Sep; 7(9):2941-8. PubMed ID: 11555613
[TBL] [Abstract][Full Text] [Related]
18. Regulation of interleukin-6-mediated PI3K activation and neuroendocrine differentiation by androgen signaling in prostate cancer LNCaP cells.
Xie S; Lin HK; Ni J; Yang L; Wang L; di Sant'Agnese PA; Chang C
Prostate; 2004 Jun; 60(1):61-7. PubMed ID: 15129430
[TBL] [Abstract][Full Text] [Related]
19. Macrophages induce neuroendocrine differentiation of prostate cancer cells via BMP6-IL6 Loop.
Lee GT; Kwon SJ; Lee JH; Jeon SS; Jang KT; Choi HY; Lee HM; Kim WJ; Lee DH; Kim IY
Prostate; 2011 Oct; 71(14):1525-37. PubMed ID: 21374653
[TBL] [Abstract][Full Text] [Related]
20. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
